Page 12 of 12
The Lancet Features PharmaJet
Needle-free jet injection for administration of influenza vaccine
August 14, 2014
Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial
2014 McAllister, L
Tags: Inactivated, Influenza, Phase 4, Respiratory Viruses, Stratis
August 3, 2014
A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
2014 Ambuel, Y
Tags: Arboviruses, Dengue, Live Attenuated, Non-Human Primate, Stratis, Tropis, Tropis/Stratis
June 5, 2014
A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
2014 Kwilas, S https://www.sciencedirect.com/science/article/pii/S0264410X21007064?via%3Dihub
Tags: ANDV, DNA, Hantaviruses, Improved Performance, Non-Human Primate, Rabbit, SNV, Stratis, Tropis, Tropis/Stratis
June 1, 2014
Minipigs as an Animal Model for Dermal Vaccine Deliver
2014 Ploemen, IHJ
Tags: Hepatitis B, Other Viruses, Pig, Protein Subunit, Tropis
February 1, 2014
A randomized controlled study to assess the immunogenicity and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a disposable syringe jet injector device versus a traditional pre-filled syringe and needle
2013 Petrovsky, N
Tags: Inactivated, Influenza, Phase 1/2, Respiratory Viruses, Stratis
September 3, 2013
Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults
2013 Soonawala, D
Tags: Inactivated, Polio, Tropis
August 12, 2013
A pilot randomized study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18–26 years
2013 Nelson, EAS
Tags: Cancer, HPV, Protein Subunit, Tropis
July 25, 2013
PharmaJet Enters into Strategic Collaboration with CureVac for Needle-Free Delivery of RNA-Based Vaccines
GOLDEN, Colo. – Feb. 22, 2013 – PharmaJet Inc. has entered into a collaboration agreement with CureVac GmbH for delivery of CureVac’s mRNA-based vaccine portfolio including targets in oncology and infectious diseases, using the PharmaJet needle-free jet injector platform.
Tags: mRNA, Nucleic Acid, Other, Stratis, Tropis, Tropis/Stratis
February 22, 2013
PharmaJet’s Stratis® Needle-Free Injector Receives WHO PQS Certification as a Pre-qualified Delivery Device for Vaccine Administration
GOLDEN, Colo. – Feb. 20, 2013 – PharmaJet Inc. has become the first and only needle-free injection company to receive Performance, Quality and Safety (PQS) pre-qualified certification from the World Health Organization (WHO).
February 20, 2013
PharmaJet Enters into Strategic Collaboration with CSL Limited for Needle‐free Delivery of Influenza Vaccines
GOLDEN, Colo. ‐ Nov. 29, 2012 – PharmaJet Inc. has entered into a collaboration with CSL Limited to enable Afluria® influenza vaccine to be delivered with the PharmaJet Stratis® needle‐free jet injector, as soon as the 2013‐2014 flu season.
November 29, 2012
Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies
2012 Ault, A
Tags: DNA, Equine Influenza, Horse, Respiratory Viruses, Tropis
June 6, 2012
FDA Grants PharmaJet 510(k) Clearance on Intradermal Needle-Free Injection Device
GOLDEN, Colo. – March 22, 2011 – The U.S. Food and Drug Administration (FDA) has awarded PharmaJet 510(k) clearance to market a 0.1mL Intradermal (ID) Needle-free Injection System.
March 22, 2011
CDC Awards Contract to PharmaJet® for Development of Needle‐Free Intradermal Vaccine Delivery Device
GOLDEN, Colo. – Jan. 27, 2011 – The Centers for Disease Control (CDC) has awarded PharmaJet with a substantial grant to develop needle-free injection devices for intradermal (ID) vaccine delivery.
January 27, 2011
Page 12 of 12